In the BioHarmony Drug Report Database

"Preview" Icon

Nelarabine

Arranon, Atriance (nelarabine) is a small molecule pharmaceutical. Nelarabine was first approved as Arranon on 2005-10-28. It is used to treat t-cell leukemia in the USA. It has been approved in Europe to treat precursor t-cell lymphoblastic leukemia-lymphoma.

 

Trade Name

 

Atriance
 

Common Name

 

nelarabine
 

ChEMBL ID

 

CHEMBL1201112
 

Indication

 

precursor t-cell lymphoblastic leukemia-lymphoma, t-cell leukemia
 

Drug Class

 

Antineoplastics (arabinofuranosyl derivatives)

Image (chem structure or protein)

Nelarabine structure rendering